Model-informed approaches to develop drug cost-saving dosing strategies for pembrolizumab. - Wang Y; Bukkems LH; van Hasselt JGC; Crombag MR; Dumoulin D; Hendrikx JJMA; Theelen W; van der Hulle T; Kapiteijn E; Zwaveling J; Becker A; Hiltermann J; et al. (European journal of cancer (Oxford, England : 1990), 2026)